Jasonlohzz
表達了心情
$Enveric Biosciences (ENVB.US)$ The Pharmaceutical Application Term Sheet Provides Enveric Biosciences Could Be Eligible To Receive Future Development And Sales Milestone Payments That In Total Could Add Up To Approximately $61M
Royalty rates could range from 2.5% up to 10% on future sales, depending on meeting certain sales criteria.
Royalty rates could range from 2.5% up to 10% on future sales, depending on meeting certain sales criteria.
4
6
Jasonlohzz
表達了心情
$SciSparc (SPRC.US)$ SciSparc Achieves Major Milestone With First Patient Dosed in Autism Spectrum Disorder Clinical Trial
GlobeNewswire· 3 mins ago
GlobeNewswire· 3 mins ago
3
6
Jasonlohzz
表達了心情
$SciSparc (SPRC.US)$ After hitting the previous 52 week low of 2.80, it rebounded to over $8. Will it happen again?
1
2
Jasonlohzz
表達了心情
已翻譯
1
2